CTNM - CIK 0001855175
Contineum Therapeutics, Inc. (CTNM) reported net income of -$59.98M for fiscal year 2025, as filed in its audited annual report with the SEC.
| Fiscal year | Net Income | Change |
|---|---|---|
| FY 2025 | -$59.98M | -41.9% |
| FY 2024 | -$42.26M | -286.0% |
| FY 2023 | $22.72M | - |
Contineum Therapeutics, Inc. (CTNM) reported net income of -$59.98M for fiscal year 2025, as filed in its audited annual report with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.